Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ·Healthcare·Biotechnology
$3.51
+2.33%
Mkt Cap $260.89M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
+42.5%
Consensus $5.00 vs current $3.51
NASDAQ·Healthcare·Biotechnology
$3.51
+2.33%
Mkt Cap $260.89M
No recent rating data.
Price Target (2 analysts)
$5.00
Range $5.00 – $5.00
+42.5%
Consensus $5.00 vs current $3.51